首页> 外文期刊>Infection and Drug Resistance >Simultaneous detection of eleven sexually transmitted agents using multiplexed PCR coupled with MALDI-TOF analysis
【24h】

Simultaneous detection of eleven sexually transmitted agents using multiplexed PCR coupled with MALDI-TOF analysis

机译:使用多重PCR和MALDI-TOF分析同时检测11种性传播药物

获取原文
           

摘要

Purpose: Sexually transmitted infections (STIs), representing a major global health problem, are caused by different microbes, including bacteria, viruses, and protozoa. Unfortunately, infections of different sexually transmitted pathogens often present similar clinical symptoms, so it is almost impossible to distinguish them clinically. Therefore, the aim of the current study was to develop a sensitive, multitarget, and high-throughput method that can detect various agents responsible for STIs. Methods: We developed and tested a 23-plex PCR coupled with matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) assay (sexually transmitted infection-mass spectrometry, STI-MS) that simultaneously targets 11 different agents, including 8 most common clinical pathogens related to STIs (HSV-1, HSV-2, Neisseria gonorrhoeae , Chlamydia trachomatis, Treponema pallidum, Trichomonas vaginalis, Mycoplasma genitalium , and Haemophilus ducreyi ) and 3 controversial microorganisms as pathogens ( Mycoplasma hominis, Ureaplasma urealyticum , and Ureaplasma parvum ). Results: The results showed that the STI-MS approach can accurately detect the expected agents, without cross-reaction with other organisms. The limit of detection of each STI-MS assay was ranged from 1.739 to 10.009 copies/reaction, using probit analyses. The verification rate for each target organism of the STI-MS ranged from a minimum of 89.3% to a maximum of 100%, using conventional assays and ultrasensitive digital PCR to confirm the STI-MS-positive results. To further evaluate the clinical performance of this assay, 241 clinical specimens (124 urethral/cervical swabs and 117 urine) were tested in parallel using the STI-MS assay and monoplex real-time PCR for each agent. The overall validation parameters of STI-MS were extremely high including sensitivity (from 85.7% to 100%), specificity (from 92.3% to 100%), PPV (from 50% to 100%), and NPV (from 99.1% to 100%) for each target. Conclusion: STI-MS is a useful high-throughput screening tool for detecting mixed infections of STIs and has great potential for application in large-scale epidemiological programs for specific microorganisms of STI.
机译:目的:性传播感染(STIs)是一种主要的全球性健康问题,由多种微生物引起,包括细菌,病毒和原生动物。不幸的是,不同性传播病原体的感染通常表现出相似的临床症状,因此几乎不可能在临床上加以区分。因此,本研究的目的是开发一种灵敏,多目标,高通量的方法,该方法可以检测出引起性传播感染的各种药物。方法:我们开发并测试了23多重PCR结合基质辅助激光解吸电离飞行时间(MALDI-TOF)质谱(MS)分析(性传播感染质谱法,STI-MS),其同时靶向11不同的病原体,包括8种与性传播感染相关的最常见临床病原体(HSV-1,HSV-2,淋病奈瑟氏球菌,沙眼衣原体,苍白螺旋体,阴道毛滴虫,生殖支原体和杜氏嗜血杆菌)和3种有争议的微生物作为病原体(Mycoplasma hominis,解脲脲原体和小脲脲原体)。结果:结果表明,STI-MS方法可以准确检测出预期的药物,而不会与其他生物发生交叉反应。使用概率分析,每个STI-MS分析的检出限范围为1.739至10.009拷贝/反应。 STI-MS的每个靶标生物的验证率范围从最小89.3%到最大100%,使用常规测定法和超灵敏数字PCR确认STI-MS阳性结果。为了进一步评估该测定法的临床性能,使用STI-MS测定法和每种试剂的实时荧光定量PCR并行测试了241个临床标本(124个尿道/宫颈拭子和117个尿液)。 STI-MS的总体验证参数非常高,包括灵敏度(从85.7%到100%),特异性(从92.3%到100%),PPV(从50%到100%)和NPV(从99.1%到100) %)。结论:STI-MS是检测STI混合感染的有用的高通量筛选工具,在针对STI特定微生物的大规模流行病学计划中具有广阔的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号